Target intelligence / Profile preview

MicroRNA 365b (miR-365b)

Target
miR-365b
Molecular classification
MicroRNA, Non-coding RNA, Gene regulator, Other
01

Overview

MicroRNA 365b (miR-365b) is a small, non-coding RNA molecule belonging to the microRNA (miRNA) family, functioning primarily in the post-transcriptional regulation of gene expression by influencing mRNA stability and translation[3][4]. Like other miRNAs, it is transcribed as a precursor transcript that is processed into a mature form and incorporated into the RNA-induced silencing complex (RISC), where it binds target mRNAs via sequence complementarity causing translation inhibition or degradation[3]. miR-365b has been implicated in the regulation of cell proliferation, cell cycle arrest, and apoptosis in cancer contexts[1][5]. Specifically, it acts as a tumor suppressor in non-small cell lung cancer cells by targeting PPP5C, leading to reduced proliferation and increased apoptosis[1]. Moreover, its expression patterns serve as potential biomarkers in cancer classification studies, such as in brain metastases and multiple myeloma[2][7][5]. No direct interacting drugs or established mechanisms of action for drug targeting are reported to date.

Other names
hsa-mir-365-2MIR365-2MIRN365-2hsa-mir-365bmir-365bmicroRNA 365-2MIR365B
02

Biological functions

Post-transcriptional gene regulationRegulation of mRNA stabilityRegulation of mRNA translationCell cycleApoptosisCell proliferationOther
03

Disease associations

CancerNon-small cell lung cancerRetinoblastomaHepatocellular carcinomaBrain metastasesMultiple myelomaOther
04

Safety considerations

Therapeutic modulation of microRNAs can lead to broad off-target effects due to diverse gene regulation; delivery and specificity challenges are known for miRNA-based therapies (inferred from general miRNA therapeutics knowledge).
05

Biomarkers

Downregulation in NSCLC (potential NSCLC biomarker)Part of a six-microRNA signature for brain metastasis classification[7]Expression signature in multiple myeloma[2]Differential expression in various cancers[1][5][7]

Beyond the preview

Go deeper on MicroRNA 365b (miR-365b).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 365b (miR-365b).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call